Woodward Company Profile

What is the competitive landscape for WOODWARD, and what generic alternatives to WOODWARD drugs are available?

WOODWARD has fourteen approved drugs.

There is one US patent protecting WOODWARD drugs.

There are twenty-four patent family members on WOODWARD drugs in fourteen countries and fourteen supplementary protection certificates in five countries.

Summary for Woodward

International Patents:	24
US Patents:	1
Tradenames:	15
Ingredients:	13
NDAs:	14

Drugs and US Patents for Woodward

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Woodward	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-003	Oct 20, 2006	AB	RX	Yes	Yes	8,101,209*PED				Y
Woodward	AVODART	dutasteride	CAPSULE;ORAL	021319-001	Nov 20, 2001	AB	RX	Yes	Yes
Woodward	DAPIPRAZOLE HYDROCHLORIDE	dapiprazole hydrochloride	SOLUTION/DROPS;OPHTHALMIC	204902-001	May 30, 2019		DISCN	No	No
Woodward	LUNESTA	eszopiclone	TABLET;ORAL	021476-003	Dec 15, 2004	AB	RX	Yes	Yes
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-003	May 25, 1999		DISCN	Yes	No
Woodward Specl	DECA-DURABOLIN	nandrolone decanoate	INJECTABLE;INJECTION	013132-002	Jun 12, 1986		DISCN	No	No

Expired US Patents for Woodward

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Woodward	LUNESTA	eszopiclone	TABLET;ORAL	021476-001	Dec 15, 2004	7,381,724*PED
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-004	May 25, 1999	5,002,953*PED
Woodward	COREG	carvedilol	TABLET;ORAL	020297-003	Sep 14, 1995	4,503,067*PED
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-002	May 25, 1999	5,741,803*PED
Woodward	COREG	carvedilol	TABLET;ORAL	020297-003	Sep 14, 1995	5,760,069*PED
Woodward	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-004	Oct 20, 2006	RE40000*PED

Paragraph IV (Patent) Challenges for WOODWARD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Extended-release Capsules	10 mg and 20 mg		2008-03-18
	Extended-release Capsules	80 mg		2007-11-19
	Capsule	0.5 mg/0.4 mg		2010-10-26
	Tablets	1 mg, 2 mg and 3 mg		2008-12-15
	Extended-release Capsules	40 mg		2007-12-21
	Capsules	0.5 mg		2007-10-29
	Capsules	1 g		2008-11-10

International Patents for Woodward Drugs

Country	Patent Number	Estimated Expiration
Brazil	PI0213175
Canada	2463134
France	2830447
Japan	4718116
Mexico	PA04003367
Brazil	0213175

Supplementary Protection Certificates for Woodward Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0268956	1999C0030	Belgium		PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508
0658161	C300035	Netherlands		PRODUCT: ROSIGLITAZONE,MALEAAT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR SOLVAAT.
0268956	SPC/GB98/040	United Kingdom		PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508
0719278	03C0030	France		PRODUCT NAME: DUTASTERIDE; NAT. REGISTRATION NO/DATE: NL 28 131 20030327; FIRST REGISTRATION: SE - 17 871 20020719
0719278	SPC/GB03/018	United Kingdom		PRODUCT NAME: DUTASTERIDE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SOLVATE.; REGISTERED: SE 17871 20020719; SE 17872 20020719; UK PL 19494/0005 20030117; UK PL 19494/0006 20030117
0719278	23/2003	Austria		PRODUCT NAME: DUTASTERIDE, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SOLVATES; NAT. REGISTRATION NO/DATE: 1-24844, 1-24845 20030217; FIRST REGISTRATION: SE 17871, 17872 20020719

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Woodward
• Woodward Specl